益菌研发

益菌研发

Research and Development
我们的品牌价值是建立在大量科学证据上

源自人体天然 A 尚好

比菲德氏菌(Bifidobacterium,常被称为双歧杆菌或简称 B 菌)为最古老的益生菌种,已与人类相伴数十万年,堪称人类最忠实的好菌,婴儿出生后肠道中有 90%为比菲德氏菌,在免疫力尚未完全建立前,作为婴幼儿的天然防护罩,因此又有「宝宝益生菌」或 「母婴益生菌」的美名,但随着年纪增长该菌数量有可能因为不良饮食、生活习惯而骤减;与其它益生菌不同,比菲德氏菌筛选自人体,且要在模拟肠道的厌氧环境中培养,世界上仅有极少数制造商能生产,最知名的便是以比菲德氏命名的韩国 bifido 公司。
人体的比菲德氏菌数量会从出生时随着年龄增长慢慢减少
最初>90%的比菲德氏菌,随年纪增长、不良饮食、作息紊乱等因素而骤减

益菌专家的坚持
最适合人体的益生菌,必须来自人体

很多益生菌即使标榜菌数高,但不适合肠道定殖,反而会被坏菌竞争后在肠道居无定所,最后被排出体外,因此最适合人体食用的益生菌并须取自于肠道而不是外部环境。
30
年开发
250+
篇文献
80+
项专利
自 1988 年起,bifido 便专注于微生物的研究,并领导首尔大学核心研究团队与韩国各大医院和研究机构进行合作研究,成功找出最优质的人体天然菌-比菲德氏,且筛出强悍的菌株,在微生物的领域中,曾发表超过 250 篇科学论文,获得 80 项专利,是微生物组领域中经验丰富的顶级专家。并在 1999 年创立 bifido 公司,打造巨大的生物反应器,可模拟人体肠道环境来培养益生菌,建造全世界最大的比菲德氏王国,在 2018 年于韩国科斯达克 KOSDAQ 股票上市,成为首家微生物发酵厂与 SAMSUNG、Hyundai、LG、SK 海力士等大型企业并列的高科技股公司。

肠道模拟器

比菲德氏菌(Bifidobacterium)不像一般的乳酸菌可轻易的从环境中取得,必须在模拟肠道的无氧的环境中培养,从菌株分离、筛选、试产及量产,均维持一条龙的无氧作业环境难度极高!

bifido 团队结合多位专家博士,建构顶尖的比菲德氏菌筛菌平台,并打造出模拟人体肠道环境的生物反应器,所以能培养出最适合人体的比菲德氏菌。

bifido 历史

bifido 从一间新创益生菌公司,到规模化生产模拟肠道无氧环境的工厂,再到韩国科斯达克 KOSDAQ 股票上市,建立全球最大的比菲德氏王国,仅花不到 20 年的时间,堪称韩国生技界的奇迹。

50 倍附着力

bifido 的比菲德氏菌经实验证实,对于肠细胞的附着能力相较于其它公司所生产的比菲德氏菌,最高可强过 50 倍之多。
bifido 公司的比菲德氏菌经实验证实,对于肠细胞的附着能力与他牌生产的比菲德氏菌相比,最高强过50倍之多。

10 倍增殖力

bifido 公司所筛选的比菲德氏菌经临床佐证,食用 1 个月,可以让肠内比菲德氏菌数量激增 10 倍。
bifido 公司所筛选的比菲德氏菌经临床佐证,食用 1 个月,可以让肠内比菲德氏菌数量激增 10 倍。
application-probio

22 项专利认可

专利编号
标题
10-0554346
A new anti-cancer polysaccharide from the genus bifidobacterium.
10-0635354
Composition for Prevention and Treatment of Food Allergy containing Bifidobacterium bifidum BGN4 as Active Ingredient.
10-1920219
Composition comprising bifidobacteria for preventing or treating of obesity.
10-1037778
Culture medium containing phytic acid for cultivation of Bifidobacterium bifidum BGN4 and method for
production of Bifidobacterium bifidum BGN4 polysaccharide using the medium.
10-1893803
Composition comprising bifidobacteria for preventing or treating of fatty liver.
10-1346739
Multiplex primer sets for detection of Bifidobacterium bifidum BGN4.
10-0492455
Bifidobacterium longum AR81 enabling inhibition of rotavirus and active protein separated therefrom.
10-1753243
Primer set for specific detection of Bifidobacterium longum BORI and method for detection of Bifidobacterium
longum BORI thereby.
10-2023700
Composition for prevention or treatment of rheumatoid arthritis with Bifidobacterium.
US 010617725B2
Composition containing Bifidobacterium for alleviating, preventing or treating rheumatoid arthritis.
10-0492455
Bifidobacterium longum RAPO for improvement, prevention or treatment of rheumatoid arthritis and composition comprising the same.
10-0442205
Bifidobacterium lactis producing β- glucosidase andmethod for converting isoflavon into isoflavon
agluconusing the same.
10-1266557
Bifidobacterium animalis BF8 (KFCC11506P) against pathogenic Enterobacter(Cronobacter) sakazakii and food composition therefrom.
10-1163101
Food composition containing the Scutellaria baicalensis George biologically converted by lactic acid bacteria or lysate of lactic acid bacteria with anti-allergenic effect.
10-1499115
Method for production of fucosyl oligosaccharides with Bifidobacterium longum RD 47.
10-1581440
Bifidobacterium longum RD 47, method for production of galactosidase from Bifidobacterium longum and
galactooligosaccharide therefrom.
10-2082315
Composition of prebiotics with butyryl-fructooligosaccharides.
US11096951B2
Prebiotic composition containing butyryl-fructooligosaccharides.
10-2253283
Method for production of human EGF with Bifidobacterium bifidum and composition thereof.
10-2314736
Composition for improvement of skin inflammation and intensification of skin barrier.
10-2343938
Composition for improving inflammation containing recombinant Bifidobacterium bifidum BGN4.
10-2362828
Composition for improvemnet, prevention or treatment of kidney injury with Bifidobacterium bifidum BGN4.
application-probio

50+ 篇文献发表

如需完整文献,欢迎联系!
研究类型
功效
年分
标题
细胞
免疫调节
2002
Cytoskeleton Reorganization and Cytokine Production of Macrophages by
Bifidobacterial Cells and Cell-free Extracts.
细胞
免疫调节
2005
Modulatory Activity of Bifidobacterium sp. BGN4 Cell Fractions on Immune Cells.
细胞
免疫调节
2012
Probiotic Modulation of Dendritic Cells Co-cultured with Intestinal Epithelial Cells.
细胞
抗发炎
2021
Lysed and disrupted Bifidobacterium bifidum BGN4 cells promote anti-inflammatory activities in lipopolysaccharide-stimulated RAW 264.7 cells.
细胞
抗发炎
2021
Production of biologically active human interleukin‑10 by Bifidobacterium bifidum BGN4.
动物
抗肥胖
2016
Anti-obese Effects of Two Lactobacilli and two Bifidobacteria on ICR mice fed on a High Fat Diet.
动物
抗过敏
2005
Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model.
动物
抗过敏
2005
Timing of Bifidobacterium administration influences the development of allergy to ovalbumin in mice.
动物
抗过敏
2006
Effect of viability and integrity of Bifidobacterium on suppression of allergy in mice.
动物
抗过敏
2005
Regulatory Effect on Specific Ige Response of Bifido Bacterium Bifidum(bgn4 Strain) in Murine Model of Peanut Allergy.
动物
抗过敏
2008
Effect of Oral Probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) Administration on Ovalbumin-Induced Food Allergy Mouse Model.
临床
抗过敏(特应性皮肤炎)
2011
Clinical Effects of Probiotics are Associated with Increased Transforming Growth Factor-β Responses in Infants with High-Risk Allergy.
临床
抗过敏(湿疹)
2010
Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus ) in the primary prevention of eczema a double‐blind, randomized, placebo‐controlled trial.
临床
抗癌
2004
Anticancerogenic effect of a novel chiroinositol-containing polysaccharide from Bifidobacterium bifidum BGN4.
细胞
抗癌
2009
Enhancement of Anti-tumorigenic Polysaccharide Production, Adhesion, and Branch Formation of Bifidobacterium bifidum BGN4 by Phytic Acid.
临床
抗轮状病毒
2017
The Efficacy of Bifidobacterium longum BORI and Lactobacillus acidophilus AD031 Probiotic Treatment in Infants with Rotavirus Infection.
细胞
抗轮状病毒
2019
The Anti-Rotaviral Activity of Low Molecular Weight and Non-Proteinaceous Substance from Bifidobacterium longum BORI Cell Extract.
细胞
肠道附着能力
2003
Characterization of Adhesion of Bifidobacterium sp. BGN4 to Human Enterocyte-Like Caco-2 Cells.
动物
促进比菲德氏菌的定殖
2017
Strain Specific Detection and Quantification of Probiotic Bifidobacterium bifidum BGN4 in Mouse Model and Positive Effect of B. bifidum BGN4 on Intestinal Microflora.
动物
改善发炎性肠道疾病
2017
Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4+ CD45RBhigh T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation.
临床
改善肠躁症
2009
Effect of Probiotics on Symptoms in Korean Adults with Irritable Bowel Syndrome.
临床
改善溃疡性肠炎
2009
The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study.
临床
腹泻为主的肠躁症
2009
Probiotic treatment induced change of inflammation related metabolites in IBS-D patients/double-blind, randomized, placebo-controlled trial.
临床
改善心情与认知功能
2021
Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community- Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
动物
认知功能(阿兹海默症模式)
2021
Administration of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI Improves Cognitive and Memory Function in the Mouse Model of Alzheimer’s Disease.
体内+体外
安全性
2009
Safety Evaluations of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI.
回顾性研究
新颖益生菌BGN4及BORI
2005
Development of Bifidobacterium sp. BGN4 and BORI with Novel Probiotic Activity.
回顾性研究
益生菌预防特应性皮肤炎
2009
Probiotics in Primary Prevention of Atopic Dermatitis.
回顾性研究
BGN4 功能及营养应用
2016
Review on Bifidobacterium bifidum BGN4: Functionality and Nutraceutical Applications as a Probiotic Microorganism.
动物
延缓脑部老化
2022
Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI promotes neuronal rejuvenation in aged mice.
临床
改善肠道发炎
2022
Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus ) in the primary prevention of eczema a double‐blind, randomized, placebo‐controlled trial.
临床
降低炎症反应
2022
The effect of probiotic supplementation on systemic inflammation in dialysis patients.
K0386  专利益生菌

本网站内容仅供企业间技术与规格交流,个别研究数据应依其特定试验条件、剂量及限制进行解读。

臻于完美,止于至善
crossmenuchevron-upchevron-downcross-circle